Skip to main content
SpringerLink
Log in

Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liu LY, Craiglow BG, Dai F, King BA. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients. J Am Acad Dermatol 2017; 76: 22–8.

    Article  CAS  Google Scholar 

  2. Kennedy Crispin M, Ko JM, Craiglow BG, et al. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 2016; 1: e89776.

    Article  Google Scholar 

  3. Gupta AK, Carviel JL, Abramovits W. Efficacy of tofacitinib in treatment of alopecia universalis in two patients. J Eur Acad Dermatol Venereol 2016; 30: 1373–8.

    Article  CAS  Google Scholar 

  4. Jabbari A, Sansaricq F, Cerise J, et al. An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis. J Invest Dermatol 2018; 138: 1539–45.

    Article  CAS  Google Scholar 

  5. Castelo-Soccio L. Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis. J Am Acad Dermatol 2017; 76: 754–5.

    Article  Google Scholar 

  6. Craiglow BG, Liu LY, King BA. Tofacitinib for the treatment of alopecia areata and variants in adolescents. J Am Acad Dermatol 2017; 76: 29–32.

    Article  CAS  Google Scholar 

  7. Shivanna CB, Shenoy C, Priya RA. Tofacitinib (selective janus kinase inhibitor 1 and 3): a promising therapy for the treatment of alopecia areata: a case report of six patients. Int J Trichol 2018; 10: 103–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

    Yang-Yi Chen, Sheng-Yiao Lin, Yin-Chun Chen & Cheng-Che E. Lan

  2. Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    Yang-Yi Chen & Cheng-Che E. Lan

  3. Department of Dermatology, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan

    Chao-Chun Yang

  4. Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    Cheng-Che E. Lan

Authors
  1. Yang-Yi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheng-Yiao Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yin-Chun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chao-Chun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cheng-Che E. Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheng-Che E. Lan.

Ethics declarations

Disclosure. Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. This study was supported by a research grant from the Ministry of Health and Welfare (MOHW108-TDU-B-212-13300). Conflicts of interest: none.

Supplementary material

Supplementary figure 1

. Clinical images of patients before and after low-dose treatment (5 mg daily for 24 weeks) with or without double-dose treatment (10 mg daily for 12 weeks).

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, YY., Lin, SY., Chen, YC. et al. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen. Eur J Dermatol 29, 667–669 (2019). https://doi.org/10.1684/ejd.2019.3668

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3668

Search

Navigation